Frontier IP Group CEO on €211M Boost for 2D Photonics
Frontier IP Group’s CEO Neil Crabb announced that its portfolio company 2D Photonics has secured a €200 million grant from the Italian government, approved by the EU, to accelerate development of advanced graphene‑based photonic chips. The funding will finance a pilot plant capable of 200 mm (eight‑inch) wafer production, demonstrating large‑scale manufacturing of graphene photonics that can transmit more data, consume less power and require less cooling than silicon, addressing the mounting demand from data‑center and large‑language‑model workloads. Crabb highlighted that Frontier holds a 9.1 % stake in 2D Photonics, translating the grant into roughly a 22‑pence per‑share uplift, and noted backing from Sony, Bosch, NATO and Italy’s sovereign wealth fund, underscoring strong institutional confidence. If successful, the technology could lower compute costs, strengthen Europe’s chip‑supply chain and boost Frontier’s valuation, while the broader portfolio—Alusid, Pulsiv, Graph Energy Tech and others—signals a strategic focus on cost‑effective, sovereign‑grade deep‑tech innovations.
Soft Robotics Inspired by Nature | Building Artificial Muscles that Move and Sense with Ryan Truby
The Nanocape episode spotlights Ryan Truby’s work at Northwestern University, where he re‑imagines robots from the inside out by replacing stiff, precision‑driven mechanisms with bio‑inspired soft materials and artificial muscles. Truby argues that the next wave of robotics must...
National Lab Discovery Series: LLNL's Massively Parallel Two-Photon Lithography Using Metaoptics
Lawrence Livermore National Laboratory unveiled a breakthrough in two‑photon lithography that replaces a single focal spot with a massive array of meta‑optics lenses. By coupling a high‑energy femtosecond laser to a spatial light modulator (SLM) and a wafer‑scale silicon metasurface...
Graphene Manufacturing Group CEO on European Sales Push, US EPA Approval
Graphene Manufacturing Group Ltd. announced two pivotal milestones: EPA clearance for its THERMAL‑XR graphene coating in the United States and the rapid deployment of a ten‑person sales force across Europe. CEO Craig Nicol highlighted that both developments are expected to...
Graphene Manufacturing Group Expands with EPA Approval & Global Growth
Graphene Manufacturing Group Ltd (GMG) secured U.S. Environmental Protection Agency approval for its THERMAL‑XR® graphene coating, clearing a regulatory hurdle that enables commercial sales in the United States. The coating is engineered to boost energy efficiency and prolong equipment life,...
This Shapeshifting Polymer Was Inspired by Octopus Skin
The video introduces a thin polymer film that mimics octopus skin, dynamically altering both colour and surface texture before reverting to its original state. Inspired by cephalopod camouflage, the material leverages fluid‑induced swelling to achieve reversible visual changes. The researchers use...
Can Nanoscience Build Better Clothes? With Cécile Chazot
Nanoscience is poised to transform clothing by re‑engineering polymers at the molecular level, a theme explored in a Nanoscape interview with Northwestern professor Cécile Chazot. Chazot explains that failure in plastics and textiles begins when molecular chains slide past each...
Group Quebec - Nanosis A Nanomedicine Design Puzzle
Group Quebec’s BioNano Engineering Group unveiled Nanosis, a Tetris‑inspired educational game that lets players assemble nanoparticles, molecular linkers, and biomolecular ligands to navigate the body’s biological barriers. Each level mirrors a stage of nanomedicine delivery—from bloodstream circulation and immune evasion...
Nanoparticles, Genome Therapy & Antibodies - The Zhou Research Lab at Yale School of Medicine
The Zhou Research Lab at Yale School of Medicine is a biomedical‑engineering group that builds platform technologies for delivering therapeutics to the brain. Its work spans three distinct avenues: engineered nanoparticles for crossing the blood‑brain barrier, a novel “step‑engineering”...
Dr. Ben Feringa | 2025 Feynman Prize Winner
Dr. Ben Feringa, 2016 Nobel laureate in chemistry, was honored with the 2025 Feynman Prize and delivered a lecture on the art of building molecular switches and motors. He framed the discussion around dynamic molecular systems that bridge chemistry, physics,...
🎙️ Nanoplastics in the Human Brain
Researchers published in the Journal of Clinical Investigation that nanoplastics can traverse the blood‑brain barrier and accumulate within human brain tissue. The study identified these ultra‑small particles, comparable in size to viruses, in both young and older individuals. Notably, brains...
Nanoplastics, mRNA Therapy, & Drug Approvals | Longevity News Roundup — Week 9, 2026
Recent longevity news highlights nanoplastics in brains, a pioneering mRNA therapy, and regulatory shifts accelerating anti‑aging drug development. Researchers found ultra‑small plastic particles accumulating in Alzheimer‑affected brain tissue, independent of age. Klothea launched a phase 1b trial of AKL003 mRNA to...
The “Art” Of the Linker: Complexity, Biodegradability, and Scale in Active LNP R&D
The panel examined the emerging “active” delivery paradigm for lipid nanoparticle (LNP) therapeutics, focusing on the added layers of complexity introduced by ligand‑modified formulations and the need for robust R&D pipelines. Participants contrasted passive LNPs with active, ligand‑decorated versions, highlighting...
Novel Lipid Chemistries & Their Impact on Passive LNP Delivery
In a recent Advancing RNA Live session, Dominik Witzigmann of NanoVation and John Zuris of Stealth Co dissected emerging lipid chemistries that enhance passive lipid nanoparticle (LNP) delivery. They highlighted breakthroughs in ionizable lipids, helper lipids, and PEG‑lipids that improve...
How Microfluidics & QbD Are Maturing LNP Manufacturing
In a recent discussion, CMC consultant Sujit Jain and NanoVation CEO Dominik Witzigmann highlighted how microfluidic platforms combined with Quality‑by‑Design (QbD) principles are transforming lipid nanoparticle (LNP) production for mRNA therapeutics. They noted that continuous‑flow microfluidics now enable precise control...